MU Yi-ming

Establishment and Characterization of a Steroidogenic Human Granulosa-Like Tumor Cell Line, KGN, That Expresses Functional Follicle-Stimulating Hormone Receptor

Yoshihiro Nishi, Toshihiko Yanase, MU Yi-ming et al. · Endocrinology · 2001 · 596 citations

Life Sciences, Cell Biology, Endocrinology +16

Insulin Sensitizer, Troglitazone, Directly Inhibits Aromatase Activity in Human Ovarian Granulosa Cells

MU Yi-ming, Toshihiko Yanase, Yoshihiro Nishi et al. · Biochemical and Biophysical Research Communications · 2000 · 141 citations

Life Sciences, Endocrinology, Pharmacology +16

Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose‐dexamethasone suppression test

MU Yi-ming, Ryoichi Takayanagi, Kyosuke Imasaki et al. · Clinical Endocrinology · 1998 · 30 citations

Medicine, Endocrinology, Pathology +17

Efficacy and safety of saxagliptin compared with acarbose in <scp>C</scp> hinese patients with type 2 diabetes mellitus uncontrolled on metformin monotherapy: <scp>R</scp> esults of a <scp>P</scp> hase <scp>IV</scp> open‐label randomized controlled study (the <scp>SMART</scp> study)

Liang Li, Hui Fang, Fengmei Xu et al. · Diabetes Obesity and Metabolism · 2017 · 23 citations

Medicine, Pharmacology, Pharmacotherapy +16

Prevalence of stroke and metabolic disorders in the middle-aged and elderly Chinese with type 2 diabetes

MU Yi-ming, Yan Wenhua, Jianming Ba et al. · Chinese Medical Journal · 2014 · 17 citations · Full text

Medicine, Geriatric Medicine, Internal Medicine +15